RecallDepth
Class III Ongoing

Clindamycin Phosphate USP, 1% (10 mg/mL), Topical Solution, 60 mL per applicator bottle, Rx only, Mfd. by: Taro Pharmaceutical Industries Ltd., Haifa Bay, Israel; Dist. by: Taro Pharmaceuticals USA, Inc., Hawthorne, NY 10532, NDC# 51672-4081-4

Company
Sun Pharmaceutical Industries Inc
Recall Initiated
November 26, 2025
Posted
January 21, 2026
Recall Number
D-0257-2026
Voluntary / Mandated
Voluntary: Firm initiated
Firm Location
Princeton, NJ, United States

Reason for Recall

Failed Impurities/Degradation: Out of Specification results for Total Impurities and for Assay.

Distribution

Nationwide in the USA.

Lot / Code Info

Lot#: AD30154, AD31143, AD31145, Exp 11/30/2025

More recalls by Sun Pharmaceutical Industries Inc

View all recalls by this company →

Other recent Class III Drug recalls